Company Profile
Tango Therapeutics Stock Price, News & Analysis
- Ticker:
- TNGX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Tango Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
28.39 USD (-0.39%)
Close
Last updated: June 23, 2026 at 00:00
4.62B USD
Market cap
Why the stock is moving
TNGX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Tango Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Tango Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Tango Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Tango Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Tango Therapeutics Appoints Robert Azelby to Board of Directors
Source: Tango Therapeutics
- 02
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering
Source: Tango Therapeutics
- 03
Tango Therapeutics Announces Proposed $500 Million Public Offering
Source: Tango Therapeutics
- 04
- 05
Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights
Source: Tango Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Tango Therapeutics (TNGX)?
Tango Therapeutics (TNGX) most recently closed at 28.39 USD, a -0.39% move versus the previous session.
What is the market cap of Tango Therapeutics (TNGX)?
Tango Therapeutics currently has a market capitalization of 4.62B USD on BioPharmSignal.
What does Tango Therapeutics do?
Tango Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is TNGX stock listed?
Tango Therapeutics (TNGX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Tango Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Tango?
Tango Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Tango Therapeutics targeting with Tango?
Tango Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Tango Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.